{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:28:24Z","timestamp":1777462104600,"version":"3.51.4"},"reference-count":19,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.ed000130","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T13:21:28Z","timestamp":1544102488000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Updating guidance for preventing and treating cryptococcal disease: how evidence and decisions interface"],"prefix":"10.1002","author":[{"given":"Chantal","family":"Migone","sequence":"first","affiliation":[{"name":"World Health Organization; Department of HIV and Global Hepatitis Programme; Geneva Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Ford","sequence":"additional","affiliation":[{"name":"World Health Organization; Department of HIV and Global Hepatitis Programme; Geneva Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Garner","sequence":"additional","affiliation":[{"name":"Liverpool School of Tropical Medicine; Centre for Evidence Synthesis in Global Health; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Eshun-Wilson","sequence":"additional","affiliation":[{"name":"Stellenbosch University; Centre for Evidence-based Health Care; Cape Town South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"10.1002\/14651858.ED000130-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"P873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.ED000130-BIB0002|cit2","volume-title":"Guidelines on the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection","author":"World Health Organization","year":"2018"},{"issue":"8","key":"10.1002\/14651858.ED000130-BIB0003|cit3","first-page":"CD004773","article-title":"Primary antifungal prophylaxis for cryptococcal disease in HIV-positive people","author":"Awotiwon","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.ED000130-BIB0004|cit4","first-page":"CD005647","article-title":"Treatment for HIV-associated cryptococcal meningitis","author":"Tenforde","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.ED000130-BIB0005|cit5","first-page":"CD009012","article-title":"Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis","author":"Eshun-Wilson","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.ED000130-BIB0006|cit6","volume-title":"Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children","author":"World Health Organization","year":"2011"},{"key":"10.1002\/14651858.ED000130-BIB0007|cit7","volume-title":"Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy","author":"World Health Organization","year":"2017"},{"issue":"7","key":"10.1002\/14651858.ED000130-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"e69288","DOI":"10.1371\/journal.pone.0069288","article-title":"Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa","volume":"8","author":"Jarvis","year":"2013","journal-title":"PLOS One"},{"issue":"1","key":"10.1002\/14651858.ED000130-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12879-017-2325-9","article-title":"Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda","volume":"17","author":"Ramachandran","year":"2017","journal-title":"BMC Infectious Diseases"},{"issue":"suppl 2","key":"10.1002\/14651858.ED000130-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/cid\/cix1143","article-title":"CD4 cell count threshold for cryptococcal antigen screening of HIV-infected individuals: a systematic review and meta-analysis","volume":"66","author":"Ford","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"9983","key":"10.1002\/14651858.ED000130-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial","volume":"385","author":"Mfinanga","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.ED000130-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1615822","article-title":"Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa","volume":"377","author":"Hakim","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.ED000130-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/jac\/dkt221","article-title":"Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal","volume":"68","author":"Loyse","year":"2013","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"12","key":"10.1002\/14651858.ED000130-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/jac\/dkw325","article-title":"Global access to antifungal therapy and its variable cost","volume":"71","author":"Kneale","year":"2016","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"11","key":"10.1002\/14651858.ED000130-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal combinations for treatment of cryptococcal meningitis in Africa","volume":"378","author":"Molloy","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.ED000130-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/653606","article-title":"Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety","volume":"51","author":"Hamill","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.ED000130-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00002030-199712000-00010","article-title":"Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis","volume":"11","author":"Leenders","year":"1997","journal-title":"AIDS"},{"key":"10.1002\/14651858.ED000130-BIB0018|cit18","volume-title":"WHO model list of essential medicines","author":"World Health Organization","year":"2017"},{"key":"10.1002\/14651858.ED000130-BIB0019|cit19","unstructured":"Gilead Sciences Gilead Sciences announces steep discounts for Ambisome to treat cryptococcal meningitis in low- and middle-income countries gilead.com\/news\/gilead-sciences-announces-steep-discounts-for-ambisome"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T19:30:39Z","timestamp":1628883039000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.ED000130"}},"subtitle":[],"editor":[{"name":"Cochrane Editorial Unit","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":19,"URL":"https:\/\/doi.org\/10.1002\/14651858.ed000130","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]}}}